Surgical Robots Market 2020 Comprehensive Analysis with Future Growth Opportunities and Forecast by 2026 | Intuitive Surgical, Accuray Incorporated, Stryker, MEDTRONIC, Smith & Nephew

Surgical Robots Market report has been formed with the appropriate expertises that utilize established and unswerving tools and techniques such as SWOT analysis and Porter's Five Forces analysis to conduct the research study. To attain knowhow of market landscape, brand awareness, latest trends, possible future issues, industry trends and customer behaviour, this finest Surgical Robots Market research report is very crucial. The report also identifies and analyses the intensifying trends along with major drivers, challenges and opportunities in the market. This market report is a source of information about General Surgery industry which puts forth current and upcoming technical and financial details of the industry to 2026.

The Surgical Robots Market report also encompasses a range of inhibitors as well as driving forces of the market which are analysed in both qualitative and quantitative manner so that readers and users get precise information and insights. All the data and statistics covered in this report are backed up by latest and proven tools and techniques. For in depth perceptive of market and competitive landscape, the report serves a lot of parameters and detailed data. The Surgical Robots Market report is prepared by performing high level market research analysis of key marketplace segments to identify opportunities, challenges, drivers, and market structures for the clients.

Global Surgical Robots Market is expected to reach USD 19,413.63 million by 2026 from USD 6,788.29 million in 2018, at a CAGR of 14.1% in the forecast period of 2019 to 2026.

Request Sample Copy of Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-surgical-robots-market

Leading Players are :

Intuitive Surgical,
Accuray Incorporated,
Stryker,
MEDTRONIC,
Smith & Nephew,
THINK Surgical, Inc.,
TransEnterix Surgical, Inc.,
Zimmer Biomet,
Verb Surgical Inc.,
Auris Health, Inc.,
Virtual Incision Corporation,
Restoration Robotics, Inc. and others.

Drivers:

RISING AGEING POPULATION:

With increasing age, the patient pool for chronic disease is rising. Older populations are more prone to diseases such as diabetes, allergies, arthritis, cardiovascular diseases, infections, gastrointestinal and other problems.

According to the U.S. census the number of people aged 65 and older in the United States on July 1, 2015 were 47.8 million.
In 2017, as per the United Nation (World Population Prospects), the number of people ageing 60 or above in the world was about 962 million, which were around 13% of the total population across the globe. This is increasing at a rate of around 3% per year.

In 2017, according to United Nations, 25% of the European population was 60 or over. It is estimated that the rapid ageing would occur in other parts of the world too, so by 2050, except for Africa, all other regions of the world will nearly have a quarter or more of their populations in the aging age group.

There are various health issues which are affected by the senior citizens such as osteoporosis, Alzheimer’s disease, osteoarthritis, diabetes, cardiovascular diseases among other diseases which are rising in the demand of surgeries. The demand for surgeries is growing but the number of doctors is decreasing, in such situation the surgical robots can be very helpful as they would help in reducing the time span of surgeries. Hence, the ageing population is expected to drive the market for the surgical robots.

RISING CASE OF ACUTE AND CHRONIC DISEASES:

The prevalence of diseases and conditions such as cardiovascular diseases, diabetes, Alzheimer’s disease, Parkinson’s disease, cancer and many others over the period of time.

According to American Cancer Society, in 2016, it is estimated that in the U.S. around 1,685,210 new cases of cancer will be diagnosed and approximately 595,690 people will die due to this disease.

According to the World Health Organization estimates, released in December 2016, there were 383000 deaths due to asthma in 2015.
According to National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), stated that in America, each year 6 in 10 adults have a chronic disease whereas 4 in 10 adults have two or more chronic diseases in the U.S.
According to Centers for Disease Control and Prevention (CDC), stated that in the U.S., each year about 610,000 people die due to heart diseases.
According to Centers for Disease Control and Prevention (CDC), stated that in America, each year about 735,000 people have a heart attack
With the increasing prevalence of chronic diseases the demand for the development and innovation of drugs and devices are increasing. This growing demand has provided an opportunity for the pharmaceutical companies to focus on introducing various products in the market in order to meet the rising demand for targeted drug delivery systems.

For instance, in 2016, Intuitive Surgical and Fosun Pharma agreed to establish a joint venture for the researching, developing, manufacturing and selling the robotic assisted catheter-based medical devices. This would help in producing the products which help in targeting the early diagnosis and cost-effective treatment of the lung cancer.

Restraints:

REGULATORY SCENARIO:

Robotics and the autonomous systems are being hailed as the fourth industrial revolution. Its impact will be felt more widely than either the computer or communications revolutions that preceded it. The exploitation of robotic technology in the healthcare setting has a great deal of potential and is an exciting area of development. Regulatory authorities are actively involved in various stages of robots development.

Two of the most important pieces of legislation in this area are:

Council Directive 93/42/EEC concerning medical devices amended by Directive 2007/47/EC) (“Medical Device Directive”)
Council Directive 90/385/EEC on the approximation of the laws of the Member states relating to active implantable medical devices (“AIMDD”)
Surgical robots fall under the regulation of the medical device directive. The FDA classifies medical devices into three categories – Class I, Class II and Class III- based on the risks associated with the device. Hence, too many rules and regulations by the government restrains the market growth.

HIGH COST OF THE EQUIPMENT AND SURGERY:

Surgical robots are the new technology that holds significant promise. One of the main factors which are restraining the growth of the market is the high cost of the equipment and the high cost of surgery involved.

For instance, robotic surgery involves a huge amount of USD 1 million to USD 2 million and ongoing annual maintenance costs of approximately of USD 250,000.
The cost of da Vinci system is very huge and expensive. The system costs more than USD 1.5 Million per unit.
The U.S. list price of CyberKnife system is around USD 4.2 Million to USD 5.75 Million based on the system configuration and the options which are purchased by the customers.
Thus, the high cost of the equipment’s and the high cost of the surgery are restraining the market to grow.

Make inquiry before buying the report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-surgical-robots-market

Opportunity:

MERGERS AND ACQUISITIONS TO EXPAND BUSINESS:

Companies dealing in surgical robots have been leveraging mergers and acquisitions, internal R&D and new partnership to expand their business in other regions, especially in promising emerging market also to increase their surgical robots market size and to grab the opportunity of surgical robots in market.

In July 2016, Zimmer Biomet (U.S.) acquired Medtech SA (France) for an estimated USD 132 million and joined the surgical robotics market. This would help the company to allow Medtech’s minimally invasive surgical robots for reaching a greater number of patients who are suffering from the spine and neurological disorders across the globe.

In April 2016, Auris Health, Inc. (U.S.) and Hansen Medical, Inc. (U.S.)signed a definitive merger agreement under which Auris has acquired Hansen Medical for USD 4.00 per share in cash or a total equity value of approximately USD 80 million.
Mergers and acquisitions will lead to expansion of business as these mergers and acquisitions will create an opportunistic scenario for surgical robotics market leading to new product development.

Challenge:

INCREASING COMPETITORS:

Intuitive Surgical is the leader in the robotics surgery space. The Da Vinci Surgical Systems developed by Intuitive Surgical was launched in 1999 that have been used in more than 3 million procedures till date around the world. Recently, Toronto based Titan Medical, unveiled recently its SPORT (Single Port Orifice Robotic Technology) surgical robot, which is similar to the Da Vinci system.

Other players also in the market include Auris surgical robotics, Cambridge, Vecna technologies, Sofar and Health robotics, Mazor Robotics, Cambridge Medical Robotics and Swisslog holds a very good position both in international market and domestic market but due to the rise in demand of innovative technology in the market.

DBMR Healthcare Robotics Digital Conference 1st and 2nd July, 2020| Register at https://www.databridgemarketresearch.com/digital-conference/future-of-healthcare-robotics

Market Trends:

Global surgical robots market is segmented into three notable segments which are product type, brands and application.

On the basis of product type, the market is segmented into robotic systems, instruments, accessories and services. In 2019, instruments segment is projected to lead with 59.3% shares and is growing with the highest CAGR of 15.1% in the forecast period of 2019 to 2026.

On the basis of brands, the market is segmented into Da Vinci surgical system, Renaissance, Cyberknife, Artas, ROSA and others. In 2019, Da Vinci surgical system segment is projected to lead with 79.6% shares and is growing with the highest CAGR of 15.2% in the forecast period of 2019 to 2026.

On the basis of application, the market is segmented into general surgery, urological, gynaecological, gastrointestinal, radiotherapy, radical prostatectomy, cardiothoracic surgery, colorectal surgery and others. In 2019, general surgery segment is projected to lead with 31.2% shares and is growing with the highest CAGR of 17.3% in the forecast period of 2019 to 2026.

Buy Full Report @ https://databridgemarketresearch.com/checkout/buy/enterprise/global-surgical-robots-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.